Cargando…

A novel exosome-derived prognostic signature and risk stratification for breast cancer based on multi-omics and systematic biological heterogeneity

Tumor heterogeneity remains a major challenge for disease subtyping, risk stratification, and accurate clinical management. Exosome-based liquid biopsy can effectively overcome the limitations of tissue biopsy, achieving minimal invasion, multi-point dynamic monitoring, and good prognosis assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Fei, Ma, Haodong, Hao, Youjin, Tian, Luyao, Li, Yinghong, Li, Bo, Chen, Juan, Tang, Ying, Li, Jing, Deng, Lili, Xie, Guoming, Liu, Mingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232662/ https://www.ncbi.nlm.nih.gov/pubmed/37273850 http://dx.doi.org/10.1016/j.csbj.2023.05.013

Ejemplares similares

A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning
por: Tian, Luyao, et al.
Publicado: (2022)

Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures
por: Deng, Lili, et al.
Publicado: (2022)

Consistent Biomarkers and Related Pathogenesis Underlying Asthma Revealed by Systems Biology Approach
por: Nie, Xiner, et al.
Publicado: (2019)

Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis
por: Wang, Xuanyi, et al.
Publicado: (2020)

Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network
por: Long, Fei, et al.
Publicado: (2022)

Junctional Epidermolysis Bullosa: Allelic Heterogeneity and Mutation Stratification for Precision Medicine
por: Condrat, Irina, et al.
Publicado: (2019)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Multi-omic stratification of the missense variant cysteinome
por: Desai, Heta, et al.
Publicado: (2023)

DECO: decompose heterogeneous population cohorts for patient stratification and discovery of sample biomarkers using omic data profiling
por: Campos-Laborie, F J, et al.
Publicado: (2019)

Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Identification of prognostic and diagnostic signatures for cancer and acute myocardial infarction: multi-omics approaches for deciphering heterogeneity to enhance patient management
por: Yuan, Na, et al.
Publicado: (2023)

Connecting omics signatures and revealing biological mechanisms with iLINCS
por: Pilarczyk, Marcin, et al.
Publicado: (2022)

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Integration of single-cell regulon atlas and multi-omics data for prognostic stratification and personalized treatment prediction in human lung adenocarcinoma
por: Xiong, Yi, et al.
Publicado: (2023)

Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
por: Xiong, Yi, et al.
Publicado: (2020)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies
por: Zou, Yanmei, et al.
Publicado: (2022)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

NESM: a network embedding method for tumor stratification by integrating multi-omics data
por: Li, Feng, et al.
Publicado: (2022)

Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma
por: Li, Ke, et al.
Publicado: (2023)

Novel exosome-related risk signature as prognostic biomarkers in glioblastoma
por: Ding, Mingyan, et al.
Publicado: (2023)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

An OMICs-based meta-analysis to support infection state stratification
por: Myall, Ashleigh C, et al.
Publicado: (2021)

Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study
por: Zhang, Jin, et al.
Publicado: (2023)

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
por: Park, Junseong, et al.
Publicado: (2019)

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
por: Tong, M, et al.
Publicado: (2016)

Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer
por: Fei, Hongjun, et al.
Publicado: (2023)

Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes
por: Pal, Sharmistha, et al.
Publicado: (2014)

Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome
por: Coelho-Silva, Juan L., et al.
Publicado: (2021)

Uncovering the prognostic gene signatures for the improvement of risk stratification in cancers by using deep learning algorithm coupled with wavelet transform
por: Zhao, Yiru, et al.
Publicado: (2020)

A signature for biological heterogeneity in susceptibility to HIV infection?
por: Nagelkerke, Nico, et al.
Publicado: (2018)

Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells
por: Luo, Hai-Tao, et al.
Publicado: (2021)

Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes
por: Zheng, Zhimin, et al.
Publicado: (2020)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eh75oe79edcc8hpgmrt4p57cj9